iHear Medical said today it closed a $4.1 million Series C-2 round of financing, with funds slated to support the upscaling of manufacturing and distribution of its hearing products. The round was led by San Leandro, Calif.-based iHear Medical’s marketing and distribution partner Ameritas, and joined by Aphelion Capital and Lighthouse Capital. “We are excited […]
Otolaryngology/Ear, Nose & Throat (ENT)
OtoNexus raises $8m for middle-ear infection tech
OtoNexus Medical Technologies raised $7.9 million to fund development of its ultrasound device used to diagnose middle-ear infections in children and determine if antibiotics are needed for treatment. The Seattle-based company sold nearly $8 million in equity of its $9.2 million offering. CEO Caitlin Cameron filed a Form D with the Securities & Exchange Commission, […]
Pediapharm wins Health Canada nod for antibiotic, steroid combo ear drop
Pediapharm Inc. (CVE:PDP) said today that it won regulatory approval from Health Canada for its Otixal eye drop solution for the treatment of acute otitis media with tympanostomy tubes in pediatric patients. The Quebec-based company touts Otixal as the 1st antibiotic and steroid combination ear drop available in single, sterile unit-dose packaging. Otitis media, or […]
Sanovas launches SinuGeniX sinus treatment subsidiary
Sanovas recently announced the launch of SinuGeniX, a wholly-owned subsidiary focused on treating chronic sinusitis with the company’s RegENT sinus treatment system. The newly-launched subsidiary won’t just supply a single tool for treating chronic sinusitis, which affects over 28 million Americans, but a suite of technologies, Sanovas CEO and system co-inventer Larry Gerrans told MassDevice.com in […]
Study uses nasal tissue to repair damaged knees
(Reuters) – Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a small experiment suggests. Researchers tested a new technique for repairing what’s known as articular cartilage, the tissue that covers the ends of bones where they come together to form […]
FDA puts Acclarent’s Aera Eustachian tube balloon in Class II
The FDA today said it reclassified Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent’s Aera Eustachian tube balloon to a Class II device. The Irvine, Calif.-based company’s Aera system consists of a balloon catheter designed to be inserted through the patient’s nose into the Eustachian tube. After insertion, the balloon is inflated to open up a pathway for mucus and […]
Report: Voice box prostheses may only last three months
(Reuters) – Tracheoesophageal voice prosthetic devices often last less than 3 months before they need to be replaced, which is a shorter lifespan than previously reported, according to a new study. “In an ideal setting, voice prostheses should last at least six months and even more ideally, up to one year,” said lead author Jan S. […]
Spirox touts 1-year results from Latera study
Spirox on Monday released 1-year results from a multi-center study of its Latera absorbable nasal implant, touting a significant reduction in nasal obstruction symptoms in patients with nasal valve collapse. Results from the study were presented at the 2016 Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery this week. “Nasal valve collapse […]
Medical society backs drug-eluting sinus implants
The American Rhinologic Society today endorsed the use of drug-eluting implants in sinus cavities for patients following surgery. A successful sinus surgery depends on proper healing and avoiding inflammation, the society said in a press release. Drug-eluting implants can reduce nasal polyps and inflammation, which can decrease a patient’s use of oral medication, according to […]
Med-El USA wins FDA nod for Synchrony EAS hearing implant
Med-El USA said today that it won pre-market approval from the FDA for its Synchrony electric acoustic stimulation hearing implant system. The Synchrony EAS uses both the Synchrony cochlear implant to stimulate the auditory nerve for high-frequency hearing loss and the Sonnet EAS audio processor for low-frequency hearing loss, the Durham, N.C.-based company said. “The […]
Acclarent wins FDA nod for Aera Eustachian tube balloon
Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent said today that it won de novo clearance from the FDA for its Aera Eustachian tube balloon dilation system, designed to treat persistent Eustachian tube dysfunction. The Irvine, Calif.-based company’s Aera system consists of a balloon catheter designed to be inserted through the patient’s nose into the Eustachian tube. After insertion, the […]